Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia

Journal of Clinical Immunology

Volumn 18, Issue 6, 1998, Pages 414-420

  Lemaire, Lucienne C J M ^a,c   Van Der Poll, Tom ^a   Van Lanschot, J Jan B ^a   Endert, Erik ^a   Buurman, Wim A ^b   Van Deventer, Sander J H ^a   Gouma, Dirk J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Lipopolysaccharide (LPS); LPS tolerance; Minimally invasive surgery

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BINDING PROTEIN; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DESENSITIZATION; ENDOTOXEMIA; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MALE; MINIMALLY INVASIVE SURGERY; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0031703662     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023282706945     Document Type: Article

References (22)

1. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jurrar D, Trentz O, Schildberg FW: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995
2. Keuter M, Dharmana E, Gasem MH, Van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WMV, Demacker PNM, Sauerwein R, Gallati H, Van der Meer J: Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169: 1306-1311, 1994
3. Munoz C, Carlet J, Fitting C, Misset B, Bierot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991
4. Van Deuren M, Van der Ven-Jongekrijg J, Demacker PNM, Bartelink AKM, Van Dalen R, Sauerwein R, Gallati H, Vannice JL, Van der Meer J: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169:157-161, 1994
5. Randow F, Syrbe U, Meisel C, Krausen D, Zuckermann H, Flatzer C, Volk HD: Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β. J Exp Med 181:1887-1892, 1995
6. Volk HD, Thieme M, Heym S, Döcke WD, Ruppe U, Tausch W, Manger D, Zuckermann S, Golosubow A, Nieter B, Reinke P, Seiler FR, Ax W, Baehr R: Alterations in function and phenotype of monocytes from patients with septic disease: Predictive value and new therapeutic strategics. Behring Inst Mitt 88:208-215, 1991
7. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nature Med 3:678-681, 1997
8. Van der Poll T, Coyle SM, Moldawer LL, Lowry SF: Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J Infect Dis 174:1356-1360, 1996
9. Lyons A, Kelly J, Rodrick ML, Mannick JA, Lederer JA: Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 226:450-460, 1997
10. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2-lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492, 1995
11. Klava A, Windsor A, Boylston AW, Reynolds JV, Ramsden CW, Guillou PJ: Monocyte activation after open and laparoscopic surgery. Br J Surg 84:1152-1156, 1997
12. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B: Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65:2283-2291, 1997
13. Berger D, Bölke E, Seidelmann M, Vasilescu C, Beger HG: Endotoxin-induced cytokine release from whole blood: Similarities between monocyte dysfunction in septic disease and during postoperative acute phase response. J Endotoxin Res 4:17-24, 1997
14. Sturk A, Joop K, Ten Cate JW, Thomas LLM: Optimalization of a chromogenic assay for endotoxin in blood. In Bacterial Endotoxins: Structure, Biomedical Significance and Detection with the Limulus Amoebocyte Lysate Test, Ten Cate JW, Büller HR, Sturk A, Levin J (eds). New York, Alan R, Liss, 1985, pp 117-136
15. Moeniralam HS, Bemelman WA, Endert E, Koopmans R, Sauerwein HP, Romijn JA: The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs. Infect Immun 65:2299-2305, 1997
16. Moeniralam HS, Enden E, Ackermans MT, Van Lanschot JJB, Sauerwein HP, Romijn JA: Sufentanil alters the inflammatory, endocrine and metabolic responses to endotoxin in dogs. Am J Physiol (in press)
17. Froon AHM, Dentener MA, Greve JWM, Ramsay G, Buurman WA: Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 171:1250-1257, 1995
18. Dentener MA, Francot GJM, Smit FT: Presence of bactericidal/ permeability-increasing protein in disease: Detection by ELISA. J Infect Dis 171:739-743, 1995
19. Van der Poll T, Jansen J, Endert E, Sauerwein HP, Van Deventer SJH: Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62:2046-2050, 1994
20. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF: Epinephrine inhibits tumor necrosis factor-α and potentiates interlcukin 10 production during human endotoxemia. J Clin Invest 97:713-719, 1996
21. Petrovsky N, Harrison LC: Diurnal rhythmicity of human cytokine production. J Immunol 158:5163-5168, 1997
22. Kimmings AN, Pajkrt D, Zaaijer K, Moojen TM, Meenan JK, Ten Cale JW, Van Deventer SJH: Factors involved in early in vitro endotoxin hyporesponsiveness in human endotoxemia. J Endotoxin Res 3:283-289, 1996